| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 3.10 | Intermediate level resistance | Recombinant | Details | Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. (Jul 1998) | ||
| Cidofovir | 3.60 | Intermediate level resistance | Recombinant | Details | Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. (Jul 1998) | ||
| Foscarnet | 1.10 | No resistance | Recombinant | Details | Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. (Jul 1998) |
| Mutant | Resistances |
|---|---|
| P522A |
Ganciclovir:
|
| P522A |
Cidofovir:
|
| P522A |
Foscarnet:
|
| P522L |
|
| P522T |
Ganciclovir:
|
| P522T |
Cidofovir:
|
| P522T |
Foscarnet:
|